Laura Korin is an expert in Hematology at Instituto Alexander Fleming (Argentina). Laura Korin has authored 33 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 112 (community average: 125). How the SLR is computed.

LeadR Profile

Laura Korin Instituto Alexander Fleming Argentina
112 ScienceLeadR Reputation 112
Network Map

Hematology

Subspecialties: Oncology - Immunology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2019 - 2026

Source: PubMed

Instituto Alexander Fleming

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 33

Citations

Citations: 107 1st author: 8 Last author: 1 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
N-AVD or BrECADD for Advanced-Stage Classical Hodgkin Lymphoma: Choosing the Right Treatment for the Right Patient.
PMID 42907308 — radiotherapy, hodgkin disease, lymphoma, therapeutics
Clin Lymphoma Myeloma Leuk20260
Mapping the capacity for geriatric blood Cancer Care in Latin America: A cross- sectional survey of current status and future priorities.
PMID 42485998 — cross-sectional studies, blood, geriatricians, hematologic neoplasms, neoplasms, geriatric assessment, transplants, research, workforce
J Geriatr Oncol20260
Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.
PMID 42314548 — lymphoma, leukemia, plasmablastic lymphoma, hiv, therapeutics, prognosis
Leuk Res20260
Accessing BTK Inhibitors and Other Novel Therapies for Mantle Cell Lymphoma: Are We All Invited to the Party?
PMID 42209392 — cells, microscopy, electron, scanning transmission, lymphoma, maintenance, rituximab, lymphoma, mantle-cell, transplants, therapeutics, transplantation
Clin Lymphoma Myeloma Leuk20260
Prevalence and survival outcomes of adult T-cell leukemia/lymphoma in Latin America: A multicenter cohort study and recommendations to improve diagnosis and outcomes.
PMID 40716284 — cells, leukemia-lymphoma, adult t-cell, lymphoma, cohort studies, leukemia, leukemia, t-cell, prevalence, diagnosis, t-lymphocytes
Cancer Epidemiol20250

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Recruiting 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT
NCT04776265 — cells, microscopy, electron, scanning transmission, brentuximab vedotin, hodgkin disease, lymphoma, stem cells, drug therapy, transplants, chemotherapy
N/ARecruiting2021

LeadR Networks

Main global connection map